Bridgefront Capital’s Hinge Health HNGE Stock Holding History

Bridgefront Capital’s Portfolio HNGE Stock Details HNGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-17,182	Closed	-$663K	–	792
2026 Q1	$663K	Buy	+17,182	New	+$714K	0.16%	207

Other funds holding HNGE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

12CM

11.2 Capital Management Las Vegas, Nevada $205M AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

DMC

Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Bridgefront Capital's HNGE Position: Q2 2026 in Review

Bridgefront Capital sold out of Hinge Health (HNGE) in Q2 2026, closing a stake of 17,182 shares — an estimated $663K sold.

Bridgefront Capital first reported a position in HNGE in Q1 2026 and held it in 1 quarter. The position peaked at $663K in Q1 2026. 276 funds tracked by Wall St. Rank hold HNGE as of Q2 2026.

Bridgefront Capital reported no remaining Hinge Health position as of Q2 2026 after selling out during the quarter.
Bridgefront Capital sold 17,182 Hinge Health shares in Q2 2026, an estimated $663K.
Bridgefront Capital first reported a position in Hinge Health in Q1 2026 and held it in 1 quarter.
Bridgefront Capital's Hinge Health position peaked at $663K in Q1 2026.
276 funds tracked by Wall St. Rank held Hinge Health as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.